Conversion

被引：15

作者：

Petersen, Ronald C.

机构：

[1] Mayo Clin, Coll Med, Mayo Alzheimer Dis Res Ctr, Rochester, MN 55905 USA

[2] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN USA

来源：

NEUROLOGY | 2006年 / 67卷 / 09期

关键词：

D O I：

10.1212/WNL.67.9_suppl_3.S12

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

An important aspect of assessing the efficacy of the outcome of the primary and secondary treatment trials concerns the topic of conversion. That is, how does one assess an end point such as the transition from normal to mild cognitive impairment (MCI) or the progression of MCI to Alzheimer disease (AD)? These can be difficult issues, but as more is learned about the intermediate states such as MCI, criteria can be developed.

引用

页码：S12 / S13

页数：2

共 9 条

[1]

American Psychiatric Asociation A, 1994, DIAGN STAT MAN MENT

[2]

Ferris S, 2005, INT PSYCHOGERIATR, V17, P242

[3] Impact of APOE genotype on the efficacy of galantamine for the treatment of mild cognitive impairment [J].

Gold, M ;

Francke, S ;

Nye, JS ;

Goldstein, HR ;

Fijal, B ;

Truyen, L ;

Cohen, N .

NEUROBIOLOGY OF AGING, 2004, 25 :S521-S521

[4] Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials [J].

Grundman, M ;

Petersen, RC ;

Ferris, SH ;

Thomas, RG ;

Aisen, PS ;

Bennett, DA ;

Foster, NL ;

Jack, CR ;

Galasko, DR ;

Doody, R ;

Kaye, J ;

Sano, M ;

Mohs, R ;

Gauthier, S ;

Kim, HT ;

Jin, S ;

Schultz, AN ;

Schafer, K ;

Mulnard, R ;

van Dyck, CH ;

Mintzer, J ;

Zamrini, EY ;

Cahn-Weiner, D ;

Thal, LJ .

ARCHIVES OF NEUROLOGY, 2004, 61 (01) :59-66

[5]

MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939

[6] Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology [J].

Petersen, RC ;

Stevens, JC ;

Ganguli, M ;

Tangalos, EG ;

Cummings, JL ;

DeKosky, ST .

NEUROLOGY, 2001, 56 (09) :1133-1142

[7] Vitamin E and donepezil for the treatment of mild cognitive impairment [J].

Petersen, RC ;

Thomas, RG ;

Grundman, M ;

Bennett, D ;

Doody, R ;

Ferris, S ;

Galasko, D ;

Jin, S ;

Kaye, J ;

Levey, A ;

Pfeiffer, E ;

Sano, M ;

van Dyck, CH ;

Thal, LJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (23) :2379-2388

[8] Mild cognitive impairment as a diagnostic entity [J].

Petersen, RC .

JOURNAL OF INTERNAL MEDICINE, 2004, 256 (03) :183-194

[9] A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment [J].

Thal, LJ ;

Ferris, SH ;

Kirby, L ;

Block, GA ;

Lines, CR ;

Yuen, E ;

Assaid, C ;

Nessly, ML ;

Norman, BA ;

Baranak, CC ;

Reines, SA .

NEUROPSYCHOPHARMACOLOGY, 2005, 30 (06) :1204-1215

← 1 →